Lockton Market Update Company Profile

21:34 EDT 23rd September 2017 | BioPortfolio

Editors, features editors and reporters are invited to quote selections from these reports and articles to enhance their own reporting. Please contact the Lockton media team for permission to reproduce an article in its entirety or to speak with a Lockton expert. Lockton retains the rights to this copyrighted work.

News Articles [14342 Associated News Articles listed on BioPortfolio]

Weed in the Workplace: What Employers Should Know

KANSAS CITY, Mo., May 24, 2017 /PRNewswire/ -- Pot is now legal in some form in 28 states and Washington, DC. Legalization of marijuana is leaving many employers scratching their heads about...

Lockton Dunning Benefits Acquires Excelsior Solutions

DALLAS, Oct. 2 2012 /PRNewswire/ -- Lockton Dunning Benefits, a Dallas-based employee benefits consulting company, today announced the acquisition of Excelsior Solutions, a leading pharmaceu...

Five Key Trends in Benefits Impacting Business Success

KANSAS CITY, Mo., July 5, 2017 /PRNewswire/ -- For employers, benefit offerings have a significant impact on the cost of doing business. Relying on traditional approaches to managing medical cost...

Update: Belgian Stem Cell Therapy Closer to Market with Phase III Launch

Update (07/06/2017): TiGenix has announced the official launch of the Phase III trial that will support the approval of Cx601, a stem cell therapy for Crohn’s disease. Originally published on 07...

Valeant Stock Needs to Clear One More Hurdle

VRX Stock: One Piece Away from a Bull Market A number of bullish events have transpired since my last update on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock. In that May 17, 2017 update, title.....

Update: After 25 years, MorphoSys Gets its First Antibody Approved

Update (19/09/2017): Janssen has received a positive CHMP opinion recommending the approval of Tremfya (guselkumab) in Europe for moderate to severe plaque psoriasis. The approval could make Tremfya t...

UPDATE: AstraZeneca’s Checkpoint Inhibitor Could be a Lung Cancer Blockbuster

UPDATE: 11/09/2017: AstraZeneca has presented impressive results at ESMO that show Imfinzi adding 11 months to patient survival, or decreasing the risk of progression by 48%, in Stage 3 NSCLC. This in...

UPDATE: Sanofi and Regeneron Score their 2nd FDA Approval of the Year

UPDATE (23/05/2017): More than six months after the FDA turned back Sanofi’s and Regeneron’s new rheumatoid arthritis (RA) drug based on manufacturing issues, the agency now handed out it...

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Dandruff [Market Basket]

Drug Facts

De-aging sunscreen spf 55 [Market America]

De-Aging Sunscreen SPF 55

De-aging moisturizing day creme with sunscreen spf 20 [Market America]

De-Aging Moisturizing Day Creme With Sunscreen SPF 20

Laura lynn extra whitening sensitive [Ingles Market Inc]

Laura Lynn Extra Whitening for Sensitive Teeth

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

PubMed Articles [779 Associated PubMed Articles listed on BioPortfolio]

Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery.

Trade-offs involved with market competition, overall costs to payers and consumers, and quality of care have not been well defined. Less competition within any given market may enable provider-driven ...

Stock Market Fluctuations and Self-Harm among Children and Adolescents in Hong Kong.

Although a few studies investigated the impact of stock market fluctuations on population health, the question of whether stock market fluctuations have an impact on self-harm in children and adolesce...

Update on tauopathies.

The purpose of this review is to provide an update on the role of tau beyond the stabilization of microtubules and on the clinical, pathological, diagnostic and therapeutic aspects of tauopathies.

Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines.

This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitud...

Biogenic amine concentrations and evolution in "chilled" Canadian pork for the Japanese market.

The aim of this study was to evaluate concentrations and evolution of biogenic amines in Canadian pork destined for the Japanese market. At 48h post-mortem, export quality loins were aged at -1.7°C f...

Clinical Trials [430 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Observational, Non-Interventional, Prospective, Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device

This study is designed to generate a comprehensive survey of the use on the market of the Anecova device within its intended indications according to the Instructions For Use. The Anecova ...

Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device

This study is a post-market clinical follow-up study. A post-market, prospective clinical trial will be conducted. The data collected from this study will serve the purpose of confirming s...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Zenith® TXD Post-market Surveillance in Japan

The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval

Companies [648 Associated Companies listed on BioPortfolio]

Lockton Market Update

Editors, features editors and reporters are invited to quote selections from these reports and articles to enhance their own reporting. Please contact the Lockton media team for permission to reprodu...

Lockton Insurance Brokers, LLC

Lockton Insurance Brokers, LLC is the Southern California subsidiary of Lockton Companies, the largest independent, privately owned, global insurance broker and benefits consultan...

Lockton Benefit Group

More than 3,800 professionals at Lockton provide more than 15,000 clients around the world with insurance, benefits, surety and risk management services, offering an uncommon level of client service. ...

Lockton Companies, LLC

In 1974, Thomas Dunning founded Dunning Insurance. What was then a small insurance agency grew into a large group employee benefits brokerage and consulting practice under the name Dunning Benefits Co...

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

More Information about "Lockton Market Update" on BioPortfolio

We have published hundreds of Lockton Market Update news stories on BioPortfolio along with dozens of Lockton Market Update Clinical Trials and PubMed Articles about Lockton Market Update for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lockton Market Update Companies in our database. You can also find out about relevant Lockton Market Update Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record